Literature DB >> 18537703

Diabetes mellitus as a risk factor for cancer: stress or viral etiology?

Melanie Cebioglu1, Hans H Schild, Olga Golubnitschaja.   

Abstract

Diabetes mellitus (DM) is a metabolic disorder. Currently over 230 million patients demonstrate already an epidemic scale of the disease. It is a lifelong progressive disease with a high mortality worldwide: every 10 seconds one patient dies on DM-related consequences. Whereas cardio-vascular complications are well-known for DM, it is relatively new consideration that diabetic patients are highly predisposed to cancer. Particularities of molecular pathomechanisms of cancer in diabetes are currently largely unclear. Disturbed glucose/insulin homeostasis is DM-specific stress factor resulting in increased production of Reactive Oxygen Species (ROS) and oxidative damage to chromosomal and mitochondrial DNA frequently observed in diabetic patients. Long-term accumulation of DNA mutations is well-acknowledged as triggering cancer. DNA-repair is highly energy consuming process which provokes increased mitochondrial activity. Particularly dangerous is a provoked activity of damaged mitochondria which leads to the "vicious circle" lowing energy supply and potentiating ROS production. Mitochondrial dysfunction is the well-acknowledged risk factor for neuro/degenerative diseases--one of possible pathomechanisms for various complications developed secondary to diabetes. At the same time, mitochondrial dysfunction might be implicated in pathomechanisms of diabetes-provoked cancer. There is a growing body of evidence that DM predisposes to almost all cancer types with some particular preferences. Frequently suffering from compromised immune response, diabetic patients is high-risk group for infectious disorders including viral infections. In its turn, viral infections are known to be implicated in cancer pathology. This review considers both stress and viral infections as possible etiology of cancer in diabetes.

Entities:  

Mesh:

Year:  2008        PMID: 18537703     DOI: 10.2174/187152608784746501

Source DB:  PubMed          Journal:  Infect Disord Drug Targets        ISSN: 1871-5265


  13 in total

1.  Chromium-picolinate therapy in diabetes care: individual outcomes require new guidelines and navigation by predictive diagnostics.

Authors:  Kristina Yeghiazaryan; Hans H Schild; Olga Golubnitschaja
Journal:  Infect Disord Drug Targets       Date:  2012-10

Review 2.  Diabetes and cancer II: role of diabetes medications and influence of shared risk factors.

Authors:  Adedayo A Onitilo; Jessica M Engel; Ingrid Glurich; Rachel V Stankowski; Gail M Williams; Suhail A Doi
Journal:  Cancer Causes Control       Date:  2012-04-25       Impact factor: 2.506

3.  Chromium-picolinate therapy in diabetes care: molecular and subcellular profiling revealed a necessity for individual outcome prediction, personalised treatment algorithms and new guidelines.

Authors:  Kristina Yeghiazaryan; Viktoriya Peeva; Aparna Shenoy; Hans H Schild; Olga Golubnitschaja
Journal:  Infect Disord Drug Targets       Date:  2011-04

4.  IFN-γ and TNF-α synergistically induce mesenchymal stem cell impairment and tumorigenesis via NFκB signaling.

Authors:  Lei Wang; Yinghua Zhao; Yi Liu; Kentaro Akiyama; Chider Chen; Cunye Qu; Yan Jin; Songtao Shi
Journal:  Stem Cells       Date:  2013-07       Impact factor: 6.277

5.  Meditation as a potential therapy for autism: a review.

Authors:  Sonia Sequeira; Mahiuddin Ahmed
Journal:  Autism Res Treat       Date:  2012-06-04

6.  Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon?

Authors:  Olga Golubnitschaja; Kristina Yeghiazaryan; Vincenzo Costigliola; Daniela Trog; Michael Braun; Manuel Debald; Walther Kuhn; Hans H Schild
Journal:  EPMA J       Date:  2013-02-19       Impact factor: 6.543

7.  Diabetes in Danish bank voles (M. glareolus): survivorship, influence on weight, and evaluation of polydipsia as a screening tool for hyperglycaemia.

Authors:  Bryan Schønecker; Tonny Freimanis; Irene Vejgaard Sørensen
Journal:  PLoS One       Date:  2011-08-04       Impact factor: 3.240

8.  Time for new guidelines in advanced diabetes care: Paradigm change from delayed interventional approach to predictive, preventive & personalized medicine.

Authors:  Olga Golubnitschaja
Journal:  EPMA J       Date:  2010-03-16       Impact factor: 6.543

9.  Cancer predisposition in diabetics: risk factors considered for predictive diagnostics and targeted preventive measures.

Authors:  Melanie Cebioglu; Hans H Schild; Olga Golubnitschaja
Journal:  EPMA J       Date:  2010-03-11       Impact factor: 6.543

10.  Inadequate diabetic care: global figures cry for preventive measures and personalized treatment.

Authors:  Babitha George; Melanie Cebioglu; Kristina Yeghiazaryan
Journal:  EPMA J       Date:  2010-03-23       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.